Vanguard Group’s RxSight RXST Stock Holding History
Bought
Maintained
Sold
Other funds holding RXST
NSGL
Vanguard Group's RXST Position: Q4 2025 in Review
Vanguard Group increased its RxSight (RXST) stake by 3.8% in Q4 2025, buying an estimated $828K and bringing the position to 2,229,539 shares worth $23.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2548.
Vanguard Group first reported a position in RXST in Q3 2021 and has held it in 18 quarters since. The position peaked at $121M in Q2 2024. 163 funds tracked by Wall St. Rank hold RXST as of Q4 2025.
- Vanguard Group held 2,229,539 shares of RxSight worth $23.2M as of Q4 2025.
- Vanguard Group bought 82,480 RxSight shares in Q4 2025, an estimated $828K.
- RxSight made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #2548 holding.
- Vanguard Group first reported a position in RxSight in Q3 2021 and has held it in 18 quarters since.
- Vanguard Group's RxSight position peaked at $121M in Q2 2024.
- 163 funds tracked by Wall St. Rank held RxSight as of Q4 2025.
Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.